Recent Advances in Drug Delivery & Formulation

Scopus Cite Score: 1.8

Indexed in: Scopus, MEDLINE/PubMed, Cabell's Directory/Journalytics

View All
Aims and Scope:
Recent Advances in Drug Delivery and Formulation publishes editorials, mini-reviews, full-length research and review articles, and short technical notes from academia, industry, and regulatory agencies worldwide. The journal’s scope covers topics related to preformulation, formulation development, manufacturing technologies, biopharmaceutics, and regulatory science of both small molecules and biomolecules. These areas include, but are not limited to pharmaceutical nanotechnology, quality by design and process analytical technology, biosimilars and biowaivers, simulation modeling. The journal also publishes guest-edited thematic issues by eminent scientists on current topics that are timely and relevant for both industry and academia. Journal’s ambition is to serve as a means for the dissemination of current fundamental and innovative science including regulatory aspects and stimulate the development of innovative technologies and products for various applications in pharmaceutical sciences and biotechnology.
Read more...

Editor-in-Chief:

  • Stefano Giovagnoli Department of Pharmaceutical Sciences
    University of Perugia
    Perugia
    Italy

ISSN: 2667-3878 (Print)

eISSN: 2667-3886 (Online)

Special Issues With Active Call for Papers

Submission closes on: Nov 23, 2026
Advances in Nanocarrier-Based Strategies for Gastrointestinal Cancer and Hepatocellular Carcinoma Therapy

The thematic issue, "Advances in Nanocarrier-Based Strategies for Gastrointestinal and Hepatic Cancer Therapy," will serve as a comprehensive platform to highlight the latest innovations and breakthroughs in nanocarrier-mediated drug delivery systems targeting gastrointestinal (GI) and hepatic cancer. This issue aims to bring together original research and critical reviews on the design, development, and clinical translation of various nanocarrier systems—including lipid-based nanoparticles, polymeric carriers, exosomes, vesicles, metal nanoparticles, and hybrid nanostructures—for the improved diagnosis, targeted delivery,... see more

Submission closes on: Oct 08, 2026
Recent Trends in GLP‑1 Formulations and Drug Delivery: Advances, Opportunities, and Challenges

Glucagon‑like peptide‑1 receptor agonists (GLP‑1 RAs) have revolutionized the management of type 2 diabetes and obesity, with emerging benefits across cardiovascular, renal, and metabolic diseases. However, their peptide nature poses significant challenges for formulation and delivery. Recent advances (2022–2025) have focused on innovative delivery modalities, including long‑acting injectables, depot systems, microneedle patches, oral peptide formulations, and non‑peptide small‑molecule agonists. Novel technologies such as stimuli‑responsive hydrogels, nanocarriers, and modular drug‑device combination products are expanding the delivery... see more